These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 22038317)
1. The role of biologics in treatment of ANCA-associated vasculitis. Dharmapalaiah C; Watts RA Mod Rheumatol; 2012 Jun; 22(3):319-26. PubMed ID: 22038317 [TBL] [Abstract][Full Text] [Related]
2. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis. Jones RB Nephron Clin Pract; 2014; 128(3-4):243-9. PubMed ID: 25401382 [TBL] [Abstract][Full Text] [Related]
3. Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents. Lenert A; Lenert P Drug Des Devel Ther; 2015; 9():333-47. PubMed ID: 25609919 [TBL] [Abstract][Full Text] [Related]
4. Impact of rituximab trials on the treatment of ANCA-associated vasculitis. Alberici F; Jayne DR Nephrol Dial Transplant; 2014 Jun; 29(6):1151-9. PubMed ID: 24126571 [TBL] [Abstract][Full Text] [Related]
5. S3. Rituximab for ANCA-associated vasculitides: the French experience. Charles P; Guillevin L Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207 [No Abstract] [Full Text] [Related]
7. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis]. Roccatello D; Vangelista A; Pani A G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261 [TBL] [Abstract][Full Text] [Related]
8. Treatment of ANCA-associated vasculitis: new therapies and a look at old entities. Zand L; Specks U; Sethi S; Fervenza FC Adv Chronic Kidney Dis; 2014 Mar; 21(2):182-93. PubMed ID: 24602467 [TBL] [Abstract][Full Text] [Related]
9. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR; Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829 [TBL] [Abstract][Full Text] [Related]
10. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. Jones RB; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh D; Walsh M; Westman K; Jayne DR; N Engl J Med; 2010 Jul; 363(3):211-20. PubMed ID: 20647198 [TBL] [Abstract][Full Text] [Related]
11. The role of rituximab in the treatment of ANCA-associated vasculitides (AAV). Daikeler T; Kistler AD; Martin PY; Vogt B; Huynh-Do U Swiss Med Wkly; 2015; 145():w14103. PubMed ID: 25658140 [TBL] [Abstract][Full Text] [Related]